Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)

NCT01077843 · clinicaltrials.gov ↗

COMPLETED

Status

27381

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Etoricoxib
DRUG: Other Cox-2 inhibitors
DRUG: Other Non-selective NSAIDs
OTHER: No anti-inflammatory treatment

Sponsor

Organon and Co